Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $52.7B |
| FY2017, ended Dec 31, 2017 | $69.2B |
| FY2018, ended Dec 31, 2018 | $55.4B |
| FY2019, ended Dec 31, 2019 | $61.2B |
| FY2020, ended Dec 31, 2020 | $76.1B |
| FY2021, ended Dec 31, 2021 | $160B |
| FY2022, ended Dec 31, 2022 | $158B |
| FY2023, ended Dec 31, 2023 | $126B |
| FY2024, ended Dec 31, 2024 | $134B |
| FY2025, ended Dec 31, 2025 | $175B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $160B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.48B |
| FY2017, ended Dec 31, 2017 | $8.62B |
| FY2018, ended Dec 31, 2018 | $10.1B |
| FY2019, ended Dec 31, 2019 | $10.7B |
| FY2020, ended Dec 31, 2020 | $11.7B |
| FY2021, ended Dec 31, 2021 | $18.5B |
| FY2022, ended Dec 31, 2022 | $20.8B |
| FY2023, ended Dec 31, 2023 | $18.8B |
| FY2024, ended Dec 31, 2024 | $19.6B |
| FY2025, ended Dec 31, 2025 | $23.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $26.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.89B | $3.26B |
| FY2017, ended Dec 31, 2017 | $2.35B | −$1.24B |
| FY2018, ended Dec 31, 2018 | $3.51B | $11.9B |
| FY2019, ended Dec 31, 2019 | $3.70B | $8.62B |
| FY2020, ended Dec 31, 2020 | $3.30B | $6.22B |
| FY2021, ended Dec 31, 2021 | $5.86B | $1.20B |
| FY2022, ended Dec 31, 2022 | $7.18B | $1.09B |
| FY2023, ended Dec 31, 2023 | $5.07B | $18.9B |
| FY2024, ended Dec 31, 2024 | $5.94B | $2.05B |
| FY2025, ended Dec 31, 2025 | $8.85B | $8.76B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.1B | $10.8B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.8B |
| FY2017, ended Dec 31, 2017 | $14.2B |
| FY2018, ended Dec 31, 2018 | $27.9B |
| FY2019, ended Dec 31, 2019 | $29.3B |
| FY2020, ended Dec 31, 2020 | $40.3B |
| FY2021, ended Dec 31, 2021 | $63.0B |
| FY2022, ended Dec 31, 2022 | $40.2B |
| FY2023, ended Dec 31, 2023 | $43.3B |
| FY2024, ended Dec 31, 2024 | $42.1B |
| FY2025, ended Dec 31, 2025 | $46.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $40.6B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.88B |
| FY2017, ended Dec 31, 2017 | $19.8B |
| FY2018, ended Dec 31, 2018 | $6.88B |
| FY2019, ended Dec 31, 2019 | $7.43B |
| FY2020, ended Dec 31, 2020 | $13.6B |
| FY2021, ended Dec 31, 2021 | $23.8B |
| FY2022, ended Dec 31, 2022 | $37.9B |
| FY2023, ended Dec 31, 2023 | $26.1B |
| FY2024, ended Dec 31, 2024 | $22.4B |
| FY2025, ended Dec 31, 2025 | $24.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $36.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 29.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.33B |
| FY2017, ended Dec 31, 2017 | 1.35B |
| FY2018, ended Dec 31, 2018 | 1.33B |
| FY2019, ended Dec 31, 2019 | 1.29B |
| FY2020, ended Dec 31, 2020 | 1.44B |
| FY2021, ended Dec 31, 2021 | 1.90B |
| FY2022, ended Dec 31, 2022 | 1.89B |
| FY2023, ended Dec 31, 2023 | 1.83B |
| FY2024, ended Dec 31, 2024 | 1.81B |
| FY2025, ended Dec 31, 2025 | 1.75B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.73B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $141M | — |
| FY2017, ended Dec 31, 2017 | $0 | $153M | — |
| FY2018, ended Dec 31, 2018 | $1.00B | $197M | — |
| FY2019, ended Dec 31, 2019 | $2.22B | $183M | — |
| FY2020, ended Dec 31, 2020 | $0 | $204M | $21.8B |
| FY2021, ended Dec 31, 2021 | $0 | $254M | — |
| FY2022, ended Dec 31, 2022 | $3.40B | $366M | — |
| FY2023, ended Dec 31, 2023 | $2.84B | $320M | — |
| FY2024, ended Dec 31, 2024 | $0 | $337M | — |
| FY2025, ended Dec 31, 2025 | $7.35B | $317M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $8.89B | $349M | — |
Valuation
At current price- Market Cap
- $154B
- P/E
- 15.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.9×
- Price / Book
- 3.1×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $26.0B
- Revenue Growth YoY
- 20.3%
- Revenue CAGR 3Y
- 4.8%
- Revenue CAGR 5Y
- 15.4%
- EPS Growth YoY
- 47.6%
- Net Income Growth YoY
- 38.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 38.8%
- FCF Margin
- 41.5%
- Return on Equity
- 20.3%
Earnings
Trailing 12 months- Net Income
- $10.1B
- EPS (diluted)
- $5.49
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $40.6B
- Total Debt
- $36.6B
- Net Cash
- $3.97B
- Total Assets
- $517B
- Total Liabilities
- $467B
- Shareholders' Equity
- $50.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $11.4B
- Capital Expenditure
- $628M
- Free Cash Flow
- $10.8B
Dividends and risk
Last 12 months- Dividend Yield
- 1.4%
- Dividend / Share
- $1.23
- Beta (5Y)
- 0.79
Every ratio is calculated from the company’s reported figures.